1,000 Alnylam Employees Across the Globe Volunteer at 5th Annual Community Service Day
September 11 2019 - 8:30AM
Business Wire
− Alnylam Supports Nearly 40 Organizations in
Greater Boston, Philadelphia, Europe and Brazil in “Helping Hands”
Community Service Day –
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi
therapeutics company, yesterday gave back to the communities where
Alnylam employees live and work at its fifth annual company-wide
“Helping Hands” Community Service Day.
The program has successfully expanded to include 1,000
employees, volunteering across 40 organizations globally,
dedicating more than 4,000 hours to local causes and organizations.
This year, for the first time, Alnylam employees who work remotely
were provided the opportunity to volunteer in the local communities
where they live.
“Each year we look forward to our ‘Helping Hands’ Community
Service Day. The concept of giving back is foundational to Alnylam,
and the energy and enthusiasm our employees bring to these worthy
organizations across the globe is palpable,” said John Maraganore,
Chief Executive Officer of Alnylam. “We are extremely grateful to
both our new partners and the organizations who continue to welcome
us back year after year.”
Activities range from supporting underserved youth, restoration
of parks, home ownership for low income families, fighting hunger,
and other neighborhood initiatives. Beneficiary organizations
include:
Nature Centers
- Boston Nature Center
- Boston Parks
- Cliveden National Trust Estate Conservation (Maidenhead,
UK)
- Woolley Firs Wildlife Trust (Maidenhead, UK)
- Emerald Necklace Conservancy
- Franklin Park Zoo
- Friends of Alewife
- Habitat Education Center
- Museum of American Bird Art
- Norton Conservation
Food Pantries and Meal Services
- Community Servings
- Cookin’ with CASPAR
- Cupboard of Kindness Food Pantry
- Greater Boston Food Bank
- TAFELN e.V. (Munich, Germany)
- Winslow Farms
Childcare and Community Programs
- Cambridge Women’s Center
- Cotting School
- Cradles to Crayons
- East End House
- Habitat for Humanity
- Harvard Square Homeless Shelter
- International Institute of New England
- Philadelphia Habitat for Humanity ReStore
- Science from Scientists
- St. Mary’s Woman and Children Center
- Stars of Hope
- Urbanity Dance
- West End House Boys and Girls Club
- Windrush Farms
- Year Up
The Company’s employees in Munich, Germany and Amsterdam,
Netherlands held their Community Service Day earlier this summer.
In addition, employees in Zug, Switzerland; Paris, France; Milan,
Italy; and Stockholm, Sweden will volunteer at local organizations
later this Fall.
About Alnylam Pharmaceuticals Alnylam (Nasdaq: ALNY) is
leading the translation of RNA interference (RNAi) into a new class
of innovative medicines with the potential to transform the lives
of people afflicted with rare genetic, cardio-metabolic, hepatic
infectious, and central nervous system/ocular diseases. Based on
Nobel Prize-winning science, RNAi therapeutics represent a
powerful, clinically validated approach for the treatment of
diseases with high unmet need. Alnylam’s first commercial RNAi
therapeutic is ONPATTRO® (patisiran), approved in the U.S., EU,
Canada, and Japan. Alnylam has a deep pipeline of investigational
medicines, including five product candidates in Phase 3 studies and
one in registration. Looking forward, Alnylam will continue to
execute on its "Alnylam 2020" strategy of building a multi-product,
commercial-stage biopharmaceutical company with a sustainable
pipeline of RNAi-based medicines to address the needs of patients
who have limited or inadequate treatment options. Headquartered in
Cambridge, MA, Alnylam employs over 1,200 people worldwide. For
more information about our people, science and pipeline, please
visit www.alnylam.com and engage with us on Twitter at @Alnylam or
on LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190911005429/en/
Alnylam Pharmaceuticals, Inc. Christine Regan Lindenboom
(Investors and Media) 617-682-4340 Josh Brodsky (Investors)
617-551-8276
Alnylam Pharmaceuticals (NASDAQ:ALNY)
Historical Stock Chart
From Aug 2024 to Sep 2024
Alnylam Pharmaceuticals (NASDAQ:ALNY)
Historical Stock Chart
From Sep 2023 to Sep 2024